Hong-jun Lin

发表

YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models

Yuquan Wei, Xiaoyun Dai, Sheng-yong Yang, 2013, British journal of pharmacology.

SKLB610: A Novel Potential Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases Inhibits Angiogenesis and Tumor Growth in Vivo

Shi-Dong Luo, Yuquan Wei, Sheng-yong Yang, 2011, Cellular Physiology and Biochemistry.

Author's response to reviews Title:A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities Authors: wenjie

Sheng-yong Yang, Hong-jun Lin, Yan Li, 2015 .

A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities

Sheng-yong Yang, Luoting Yu, Wenjie Lu, 2015, BMC Cancer.

Pharmacokinetic studies of a novel multikinase inhibitor for treating cancer by HPLC-UV.

Sheng-yong Yang, Ningyu Wang, Luoting Yu, 2013, Journal of chromatographic science.

Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo.

Luoting Yu, Yan Zhou, Hong-jun Lin, 2011, Cancer letters.

Chloroquine potentiates the anticancer effect of sunitinib on renal cell carcinoma by inhibiting autophagy and inducing apoptosis

Hong-jun Lin, Yan Li, Ying-Lan Zhao, 2017, Oncology letters.

YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models

Yuquan Wei, You-Li Pan, Q. Lei, 2014, Scientific Reports.

1H-NMR based metabonomic profiling of human esophageal cancer tissue

X. Cen, Wenjie Lu, Pengchi Deng, 2013, Molecular Cancer.

NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration

Qian Bu, Guangyan Yan, Yanli Wang, 2010, Nanotechnology.

SKLB70326, a novel small-molecule inhibitor of cell-cycle progression, induces G₀/G₁ phase arrest and apoptosis in human hepatic carcinoma cells.

Li Yang, Xiaoyun Dai, Jiyan Liu, 2012, Biochemical and biophysical research communications.

A Novel Anticancer Agent, SKLB70359, Inhibits Human Hepatic Carcinoma Cells proliferation via G0/G1 Cell Cycle Arrest and Apoptosis Induction

Luoting Yu, Hong-jun Lin, Ying-Lan Zhao, 2012, Cellular Physiology and Biochemistry.

Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists.

Hang Song, Yongmei Xie, Y. Sang, 2014, Bioorganic & medicinal chemistry letters.

Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability

F. Gao, Li Yang, Jiyan Liu, 2011, Journal of Molecular Medicine.

Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: Efficient suppression of growth of multiple myeloma in a murine model

Yuquan Wei, Z. Qian, Yinglan Zhao, 2012, Oncology reports.

Validation of a high-performance liquid chromatographic ultraviolet detection method for the quantification of vandetanib in rat plasma and its application to pharmacokinetic studies.

Yinglan Zhao, Youzhi Xu, Hong-jun Lin, 2014, Journal of cancer research and therapeutics.

Comparative Proteomic Approach Identifies Pkm2 and Cofilin-1 as Potential Diagnostic, Prognostic and Therapeutic Targets for Pulmonary Adenocarcinoma

Ying-wei Xie, Ming-hai Tang, F. Gong, 2011, PloS one.

YL4073 is a potent autophagy-stimulating antitumor agent in an in vivo model of Lewis lung carcinoma.

K. Lu, Li-xin Kan, Hong-jun Lin, 2016, Oncology reports.

A Novel Anticancer Agent, SKLB70359, Inhibits Human Hepatic Carcinoma Cells proliferation via G0/G1 Cell Cycle Arrest and Apoptosis Induction

Hong-jun Lin, Ying-Lan Zhao, G. Xie, 2012, Cellular Physiology and Biochemistry.